- Report
- August 2024
- 137 Pages
Global
From €2664EUR$2,999USD£2,311GBP
- Report
- July 2024
- 100 Pages
Global
From €3331EUR$3,750USD£2,890GBP
- Report
- February 2024
- 150 Pages
Global
From €4219EUR$4,750USD£3,661GBP
- Report
- August 2025
- 88 Pages
Global
From €2216EUR$2,495USD£1,923GBP
The Fortum market is a segment of the antibiotics industry that focuses on the development and production of antibiotics for the treatment of bacterial infections. It is a highly competitive market, with a wide range of products available to meet the needs of different patients. The market is driven by the need for effective treatments for bacterial infections, as well as the increasing demand for antibiotics due to the rise in antibiotic resistance.
The Fortum market is composed of a variety of companies, ranging from large pharmaceutical companies to smaller biotechnology firms. These companies are involved in the research, development, and production of antibiotics, as well as the marketing and distribution of these products. Some of the major players in the Fortum market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more